GlassScriptPhysician profile
Edward J Arous
NPI 1982999199
$29,096.47
in general payments reported to CMS, 2019-2025
32 companies · $1,455 in 2025
The $1,455 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,336 · 2020: $252 · 2021: $1,843 · 2022: $4,458 · 2023: $16K · 2024: $2,368 · 2025: $1,455.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $11K · Food and Beverage: $5,500 · Education: $1,950 · Travel and Lodging: $1,458 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $10,500.00 |
| Food and Beverage | $5,499.73 |
| Education | $1,950.00 |
| Travel and Lodging | $1,458.02 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $800.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $14,850.98 | 2021-2025 | (6554) Periph Vasc Undiv, Zenition 90, Specialty Tempus Ic Monitor |
| Medtronic, INC. | $4,078.93 | 2021-2025 | Silverhawk, Turbohawk, Endurant Iis |
| Veryan Medical Incorporated | $2,496.38 | 2021-2023 | Biomimics 3d Vascular Stent System |
| Penumbra, INC. | $1,780.97 | 2019-2022 | |
| Silk Road Medical, INC. | $1,439.31 | 2021-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Boston Scientific Corporation | $910.89 | 2020-2025 | Varithena Administration Pack |
| Aesculap Implant Systems, LLC | $636.98 | 2019 | |
| Endologix LLC | $569.10 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $510.41 | 2021-2023 | Xarelto |
| Cook Medical LLC | $471.23 | 2023-2025 | Rosen, Cook |
| W. L. Gore & Associates, INC. | $247.47 | 2022-2024 | Gore Viabahn Endoprosthesis |
| Bard Peripheral Vascular, INC. | $173.58 | 2021-2024 | Rotarexs 6 F X 135 Cm |
| Abbott Laboratories | $146.00 | 2023 | Jeti Peripheral Catheter, Xience Sierra |
| Argon Medical Devices, INC. | $99.14 | 2021 | |
| Bolton Medical INC | $97.84 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $72.51 | 2023-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Organogenesis INC. | $70.09 | 2021-2025 | Puraply Wound Matrix, Puraply |
| Cordis US Corp. | $68.29 | 2023 | |
| Lemaitre Vascular, INC. | $56.00 | 2022-2025 | Xenosure Biologic Patch, Artegraft Vascular Graft |
| Stryker Corporation | $55.80 | 2025 | Clottriever Bold Catheter, Limflow System |
| Smith+Nephew, INC. | $52.76 | 2021-2024 | Collagenase Santyl |
| Innovation Technologies INC | $48.70 | 2024 | Irrisept |
| Aroa Biosurgery Incorporated | $34.78 | 2024 | |
| Cvrx, INC. | $29.83 | 2022 | |
| Getinge USA Sales, LLC | $24.91 | 2022 | |
| Mimedx Group, INC. | $23.94 | 2024 | |
| Asahi Intecc USA, INC. | $18.64 | 2025 | Asahi Peripheral Vascular Wires |
| Sanara Medtech INC. | $15.84 | 2025 | Biasurge |
| Cardiovascular Systems INC. | $15.17 | 2021 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$75,001.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Arous listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.